Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

samuel rabkin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Physiology

Procedures

Anatomy

Disorders

Brain Neoplasms

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Passer B J; Castelo-Branco P; Buhrman J S; Varghese S; Rabkin S D; Martuza R L
Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.
Wakimoto Hiroaki; Kesari Santosh; Farrell Christopher J; Curry William T; Zaupa Cecile; Aghi Manish; Kuroda Toshihiko; Stemmer-Rachamimov Anat; Shah Khalid; Liu Ta-Chiang; Jeyaretna Deva S; Debasitis Jason; Pruszak Jan; Martuza Robert L; Rabkin Samuel D
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.
Aghi Manish K; Liu Ta-Chiang; Rabkin Samuel; Martuza Robert L
Hypoxia enhances the replication of oncolytic herpes simplex virus.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of samuel rabkin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Passer B J; Castelo-Branco P; Buhrman J S; Varghese S; Rabkin S D; Martuza R L
Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.
Cancer gene therapy 2009;16(7):551-60.
2009: Wakimoto Hiroaki; Kesari Santosh; Farrell Christopher J; Curry William T; Zaupa Cecile; Aghi Manish; Kuroda Toshihiko; Stemmer-Rachamimov Anat; Shah Khalid; Liu Ta-Chiang; Jeyaretna Deva S; Debasitis Jason; Pruszak Jan; Martuza Robert L; Rabkin Samuel D
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.
Cancer research 2009;69(8):3472-81.
2009: Aghi Manish K; Liu Ta-Chiang; Rabkin Samuel; Martuza Robert L
Hypoxia enhances the replication of oncolytic herpes simplex virus.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(1):51-6.
2008: Farrell Christopher J; Zaupa Cecile; Barnard Zachary; Maley Jason; Martuza Robert L; Rabkin Samuel D; Curry William T
Combination immunotherapy for tumors via sequential intratumoral injections of oncolytic herpes simplex virus 1 and immature dendritic cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7711-6.
2008: Farassati Faris; Pan Weihong; Yamoutpour Farnaz; Henke Susann; Piedra Mark; Frahm Silke; Al-Tawil Said; Mangrum Wells I; Parada Luis F; Rabkin Samuel D; Martuza Robert L; Kurtz Andreas
Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.
The American journal of pathology 2008;173(6):1861-72.
2008: Liu Ta-Chiang; Castelo-Branco Pedro; Rabkin Samuel D; Martuza Robert L
Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(6):1041-7.
2007: Varghese Susan; Rabkin Samuel D; Nielsen G Petur; MacGarvey Usha; Liu Renbin; Martuza Robert L
Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.
Cancer research 2007;67(19):9371-9.
2007: Liu Ta-Chiang; Wakimoto Hiroaki; Martuza Robert L; Rabkin Samuel D
Herpes simplex virus Us3(-) mutant as oncolytic strategy and synergizes with phosphatidylinositol 3-kinase-Akt targeting molecular therapeutics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(19):5897-902.
2007: Prabhakar S; Messerli S M; Stemmer-Rachamimov A O; Liu T-C; Rabkin S; Martuza R; Breakefield X O
Treatment of implantable NF2 schwannoma tumor models with oncolytic herpes simplex virus G47Delta.
Cancer gene therapy 2007;14(5):460-7.
2007: Aghi Manish; Rabkin Samuel D; Martuza Robert L
Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.
Cancer research 2007;67(2):440-4.
2007: Jeyaretna Deva S; Rabkin Samuel D; Martuza Robert L
Oncolytic herpes simplex virus therapy for peripheral nerve tumors.
Neurosurgical focus 2007;22(6):E4.
2006: Liu Ta-Chiang; Zhang Tingguo; Fukuhara Hiroshi; Kuroda Toshihiko; Todo Tomoki; Martuza Robert L; Rabkin Samuel D; Kurtz Andreas
Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;14(6):789-97.
2006: Liu Ta-Chiang; Zhang Tingguo; Fukuhara Hiroshi; Kuroda Toshihiko; Todo Tomoki; Canron Xavier; Bikfalvi Andreas; Martuza Robert L; Kurtz Andreas; Rabkin Samuel D
Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6791-9.
2006: Kuroda Toshihiko; Rabkin Samuel D; Martuza Robert L
Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
Cancer research 2006;66(20):10127-35.
2006: Varghese Susan; Rabkin Samuel D; Nielsen Petur G; Wang Wenzheng; Martuza Robert L
Systemic oncolytic herpes virus therapy of poorly immunogenic prostate cancer metastatic to lung.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2919-27.
2006: Varghese S; Rabkin S D; Liu R; Nielsen P G; Ipe T; Martuza R L
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.
Cancer gene therapy 2006;13(3):253-65.
2006: Messerli Shanta M; Prabhakar Shilpa; Tang Yi; Mahmood Umar; Giovannini Marco; Weissleder Ralph; Bronson Rodrick; Martuza Robert; Rabkin Samuel; Breakefield Xandra O
Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2.
Human gene therapy 2006;17(1):20-30.
2006: Aghi Manish; Rabkin Samuel; Martuza Robert L
Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
Journal of the National Cancer Institute 2006;98(1):38-50.
2006: Aghi Manish; Rabkin Samuel; Martuza Robert L
Oncolytic herpes simplex virus mutants exhibit enhanced replication in glioma cells evading temozolomide chemotherapy through deoxyribonucleic acid repair.
Clinical neurosurgery 2006;53():65-76.
2006: Kuroda Toshihiko; Martuza Robert L; Todo Tomoki; Rabkin Samuel D
Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.
BMC biotechnology 2006;6():40.
2005: Fukuhara Hiroshi; Martuza Robert L; Rabkin Samuel D; Ito Yoshikazu; Todo Tomoki
Oncolytic herpes simplex virus vector g47delta in combination with androgen ablation for the treatment of human prostate adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7886-90.
2005: Aghi Manish; Rabkin Samuel
Viral vectors as therapeutic agents for glioblastoma.
Current opinion in molecular therapeutics 2005;7(5):419-30.
2005: Liu R; Martuza R L; Rabkin S D
Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain.
Gene therapy 2005;12(8):647-54.
2005: Liu Ren-bin; Rabkin Samuel D
Oncolytic herpes simplex virus vectors for the treatment of human breast cancer.
Chinese medical journal 2005;118(4):307-12.
2005: Liu Renbin; Varghese Susan; Rabkin Samuel D
Oncolytic herpes simplex virus vector therapy of breast cancer in C3(1)/SV40 T-antigen transgenic mice.
Cancer research 2005;65(4):1532-40.
2005: Doolittle Nancy D; Abrey Lauren E; Bleyer W Archie; Brem Steven; Davis Thomas P; Dore-Duffy Paula; Drewes Lester R; Hall Walter A; Hoffman John M; Korfel Agnieszka; Martuza Robert; Muldoon Leslie L; Peereboom David; Peterson Darryl R; Rabkin Samuel D; Smith Quentin; Stevens Glen H J; Neuwelt Edward A
New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):421-8.
2003: Jasmin Luc; Rabkin Samuel D; Granato Alberto; Boudah Abdennacer; Ohara Peter T
Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex.
Nature 2003;424(6946):316-20.
2002: Varghese Susan; Rabkin Samuel D
Oncolytic herpes simplex virus vectors for cancer virotherapy.
Cancer gene therapy 2002;9(12):967-78.
2001: Jorgensen T J; Katz S; Wittmack E K; Varghese S; Todo T; Rabkin S D; Martuza R L
Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer.
Neoplasia (New York, N.Y.) 2001;3(5):451-6.
2001: Varghese S; Newsome J T; Rabkin S D; McGeagh K; Mahoney D; Nielsen P; Todo T; Martuza R L
Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates.
Human gene therapy 2001;12(8):999-1010.
2001: Todo T; Martuza R L; Rabkin S D; Johnson P A
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(11):6396-401.
2001: Mashour G A; Moulding H D; Chahlavi A; Khan G A; Rabkin S D; Martuza R L; Driever P H; Kurtz A;
Therapeutic efficacy of G207 in a novel peripheral nerve sheath tumor model.
Experimental neurology 2001;169(1):64-71.
2001: Wu A; Mazumder A; Martuza R L; Liu X; Thein M; Meehan K R; Rabkin S D
Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantation.
Cancer research 2001;61(7):3009-15.
2001: Toda M; Martuza R L; Rabkin S D
Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine.
Gene therapy 2001;8(4):332-9.
2001: Todo T; Martuza R L; Dallman M J; Rabkin S D
In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
Cancer research 2001;61(1):153-61.
2000: Todo T; Feigenbaum F; Rabkin S D; Lakeman F; Newsome J T; Johnson P A; Mitchell E; Belliveau D; Ostrove J M; Martuza R L
Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(6):588-95.
2000: Toda M; Martuza R L; Rabkin S D
Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(4):324-9.
2000: Jasmin L; Janni G; Ohara P T; Rabkin S D
CNS induced neurogenic cystitis is associated with bladder mast cell degranulation in the rat.
The Journal of urology 2000;164(3 Pt 1):852-5.
2000: Moulding H D; Martuza R L; Rabkin S D
Clinical mutations in the L1 neural cell adhesion molecule affect cell-surface expression.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(15):5696-702.
2000: Todo T; Rabkin S D; Martuza R L
Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors.
Cancer gene therapy 2000;7(6):939-46.
2000: Markert J M; Medlock M D; Rabkin S D; Gillespie G Y; Todo T; Hunter W D; Palmer C A; Feigenbaum F; Tornatore C; Tufaro F; Martuza R L
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.
Gene therapy 2000;7(10):867-74.
2000: Sundaresan P; Hunter W D; Martuza R L; Rabkin S D
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice.
Journal of virology 2000;74(8):3832-41.
1999: Todo T; Rabkin S D; Chahlavi A; Martuza R L
Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy.
Human gene therapy 1999;10(17):2869-78.
1999: Todo T; Rabkin S D; Sundaresan P; Wu A; Meehan K R; Herscowitz H B; Martuza R L
Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus.
Human gene therapy 1999;10(17):2741-55.
1999: Chahlavi A; Rabkin S; Todo T; Sundaresan P; Martuza R
Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice.
Gene therapy 1999;6(10):1751-8.
1999: Walker J R; McGeagh K G; Sundaresan P; Jorgensen T J; Rabkin S D; Martuza R L
Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207.
Human gene therapy 1999;10(13):2237-43.
1999: Hunter W D; Martuza R L; Feigenbaum F; Todo T; Mineta T; Yazaki T; Toda M; Newsome J T; Platenberg R C; Manz H J; Rabkin S D
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates.
Journal of virology 1999;73(8):6319-26.
1999: Chahlavi A; Todo T; Martuza R L; Rabkin S D
Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.
Neoplasia (New York, N.Y.) 1999;1(2):162-9.
1999: Miyatake S I; Tani S; Feigenbaum F; Sundaresan P; Toda H; Narumi O; Kikuchi H; Hashimoto N; Hangai M; Martuza R L; Rabkin S D
Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo.
Gene therapy 1999;6(4):564-72.
1999: Toda M; Rabkin S D; Kojima H; Martuza R L
Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity.
Human gene therapy 1999;10(3):385-93.
1998: New K C; Rabkin S D
GABA synthesis in astrocytes after infection with defective herpes simplex virus vectors expressing glutamic acid decarboxylase 65 or 67.
Journal of neurochemistry 1998;71(6):2304-12.
1998: Jasmin L; Janni G; Manz H J; Rabkin S D
Activation of CNS circuits producing a neurogenic cystitis: evidence for centrally induced peripheral inflammation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(23):10016-29.
1998: New K C; Gale K; Martuza R L; Rabkin S D
Novel synthesis and release of GABA in cerebellar granule cell cultures after infection with defective herpes simplex virus vectors expressing glutamic acid decarboxylase.
Brain research. Molecular brain research 1998;61(1-2):121-35.
1998: Toda M; Rabkin S D; Martuza R L
Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.
Human gene therapy 1998;9(15):2177-85.
1998: Toda M; Martuza R L; Kojima H; Rabkin S D
In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(9):4457-64.
1997: Miyatake S; Martuza R L; Rabkin S D
Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma.
Cancer gene therapy 1997;4(4):222-8.
1997: Miyatake S; Iyer A; Martuza R L; Rabkin S D
Transcriptional targeting of herpes simplex virus for cell-specific replication.
Journal of virology 1997;71(7):5124-32.
1996: Rabkin S D; Mineta T; Miyatake S; Yazaki T
Gene therapy: targeting tumor cells for destruction.
Human cell : official journal of Human Cell Research Society 1996;9(4):265-76.
1996: Yazaki T; Martuza R L; Rabkin S D
Expression of L1 in primary astrocytes via a defective herpes simplex virus vector promotes neurite outgrowth and neural cell migration.
Brain research. Molecular brain research 1996;43(1-2):311-20.
1996: Yazaki T; Ahmad S; Chahlavi A; Zylber-Katz E; Dean N M; Rabkin S D; Martuza R L; Glazer R I
Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.
Molecular pharmacology 1996;50(2):236-42.
1996: New K C; Rabkin S D
Co-expression of two gene products in the CNS using double-cassette defective herpes simplex virus vectors.
Brain research. Molecular brain research 1996;37(1-2):317-23.
1995: Yazaki T; Manz H J; Rabkin S D; Martuza R L
Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1.
Cancer research 1995;55(21):4752-6.
1995: Mineta T; Rabkin S D; Yazaki T; Hunter W D; Martuza R L
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
Nature medicine 1995;1(9):938-43.
1995: Yazaki T; Takamiya Y; Costello P C; Mineta T; Menon A G; Rabkin S D; Martuza R L
Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470.
Journal of neuro-oncology 1995;23(1):23-9.
1994: Wood M J; Byrnes A P; Kaplitt M G; Pfaff D W; Rabkin S D; Charlton H M
Specific patterns of defective HSV-1 gene transfer in the adult central nervous system: implications for gene targeting.
Experimental neurology 1994;130(1):127-40.
1994: Verhaagen J; Hermens W T; Oestreicher A B; Gispen W H; Rabkin S D; Pfaff D W; Kaplitt M G
Expression of the growth-associated protein B-50/GAP43 via a defective herpes-simplex virus vector results in profound morphological changes in non-neuronal cells.
Brain research. Molecular brain research 1994;26(1-2):26-36.
1994: Kaplitt M G; Kwong A D; Kleopoulos S P; Mobbs C V; Rabkin S D; Pfaff D W
Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(19):8979-83.
1994: Wood M J; Byrnes A P; Pfaff D W; Rabkin S D; Charlton H M
Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors.
Gene therapy 1994;1(5):283-91.
1994: Mineta T; Rabkin S D; Martuza R L
Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant.
Cancer research 1994;54(15):3963-6.
1994: Wood M J; Byrnes A P; Rabkin S D; Pfaff D W; Charlton H M
Immunological consequences of HSV-1-mediated gene transfer into the CNS.
Gene therapy 1994;1 Suppl 1():S82.
1994: New K C; Martuza R L; Rabkin S D
Defective herpes simplex virus vectors for the study of promoter and gene function in the CNS.
Gene therapy 1994;1 Suppl 1():S79.
1994: Mineta T; Markert J M; Takamiya Y; Coen D M; Rabkin S D; Martuza R L
CNS tumor therapy by attenuated herpes simplex viruses.
Gene therapy 1994;1 Suppl 1():S78.
1994: Kaplitt M G; Tjuvajev J G; Leib D A; Berk J; Pettigrew K D; Posner J B; Pfaff D W; Rabkin S D; Blasberg R G
Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats.
Journal of neuro-oncology 1994;19(2):137-47.
1992: Clarke P; Rabkin S D; Inman M V; Mahalingam R; Cohrs R; Wellish M; Gilden D H
Molecular analysis of simian varicella virus DNA.
Virology 1992;190(2):597-605.
1991: Rabkin S D; Hanlon B
Nucleoprotein complex formed between herpes simplex virus UL9 protein and the origin of DNA replication: inter- and intramolecular interactions.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(23):10946-50.
1991: Kaplitt M G; Pfaus J G; Kleopoulos S P; Hanlon B A; Rabkin S D; Pfaff D W
Expression of a functional foreign gene in adult mammalian brain following in Vivo transfer via a herpes simplex virus type 1 defective viral vector.
Molecular and cellular neurosciences 1991;2(4):320-30.
1990: Rabkin S D; Hanlon B
Herpes simplex virus DNA synthesis at a preformed replication fork in vitro.
Journal of virology 1990;64(10):4957-67.
1990: Rabkin S D; Richardson C C
In vivo analysis of the initiation of bacteriophage T7 DNA replication.
Virology 1990;174(2):585-92.
1988: Rabkin S D; Richardson C C
Initiation of DNA replication at cloned origins of bacteriophage T7.
Journal of molecular biology 1988;204(4):903-16.
1986: Strauss B; Larson K; Rabkin S; Sagher D; Sahm J; Shenkar R
In vitro models for mutagenesis: a role for lesion, polymerase and sequence.
Progress in clinical and biological research 1986;209A():149-59.
1986: Strauss B; Larson K; Rabkin S; Sagher D; Sahm J
Termination of synthesis resulting from modifying bases in DNA.
IARC scientific publications 1986;(70):387-92.
1985: Strauss B S; Larson K; Sagher D; Rabkin S; Shenkar R; Sahm J
In vitro models of mutagenesis.
Carcinogenesis; a comprehensive survey 1985;10():481-93.
1984: Rabkin S D; Strauss B S
A role for DNA polymerase in the specificity of nucleotide incorporation opposite N-acetyl-2-aminofluorene adducts.
Journal of molecular biology 1984;178(3):569-94.
1983: Rabkin S D; Moore P D; Strauss B S
In vitro bypass of UV-induced lesions by Escherichia coli DNA polymerase I: specificity of nucleotide incorporation.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(6):1541-5.
1982: Moore P D; Rabkin S D; Osborn A L; King C M; Strauss B S
Effect of acetylated and deacetylated 2-aminofluorene adducts on in vitro DNA synthesis.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(23):7166-70.
1982: Moore P D; Rabkin S D; Osborn A L; Strauss B S
Interactions between DNA polymerase and aminofluorene adducts that affect the recognition and possibly the mutagenicity of the lesions.
Biochimie 1982;64(8-9):757-62.
1982: Moore P D; Rabkin S D; Strauss B S
In vitro replication of mutagen-damaged DNA: sites of termination.
Basic life sciences 1982;20():179-97.
1981: Moore P D; Bose K K; Rabkin S D; Strauss B S
Sites of termination of in vitro DNA synthesis on ultraviolet- and N-acetylaminofluorene-treated phi X174 templates by prokaryotic and eukaryotic DNA polymerases.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(1):110-4.
1980: Moore P D; Rabkin S D; Strauss B S
Termination of vitro DNA synthesis at AAF adducts in the DNA.
Nucleic acids research 1980;8(19):4473-84.
1979: Becker Y; Gutter B; Cohen Y; Chejanovsky N; Rabkin S; Fridlender B
Herpes simplex virus DNA polymerase, thymidine kinase and deoxyribonuclease activities in cells infected with wild type, ultraviolet-irradiated and defective virus.
Archives of virology 1979;62(3):163-74.
1978: Becker Y; Asher Y; Weinberg-Zahlering E; Rabkin S; Friedmann A; Kessler E
Defective herpes simplex virus DNA: circular and circular-linear molecules resembling rolling circles.
The Journal of general virology 1978;40(2):319-35.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

samuel rabkin

Research Profile (preview)

Living Beings

Chemicals & Drugs

Physiology

Procedures

Anatomy

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of samuel rabkin (preview)

All Publications